All Stories

  1. New Devices for Endoscopic Treatments in Gastroenterology: A Narrative Review
  2. Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update
  3. Reply
  4. Extracorporeal shock wave lithotripsy for difficult common bile duct stones: a comparison between 2 different lithotripters in a large cohort of patients
  5. Guidewire stent cannulation and sphincterotome-assisted extraction of proximally migrated biliary plastic stent
  6. Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers
  7. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: A prospective study
  8. Tu1265 Mediterranean Diet (MD) Efficacy in Patients With Slow Transit Constipation (STC)
  9. Su1672 Extracorporeal Shock Wave Lithotripsy for Difficult Common Bile Duct Stones: Comparison Between Two Different Lithotripters in a Large Cohort of Patients
  10. Berberine and Its Metabolites: Relationship between Physicochemical Properties and Plasma Levels after Administration to Human Subjects
  11. OC.19.4 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR DIFFICULT COMMON BILE DUCT STONES: COMPARISON BETWEEN SECOND AND THIRD-GENERATION LITHOTRIPTERS IN A LARGE COHORT OF PATIENTS
  12. Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma
  13. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis
  14. Treatment with telbivudine for fulminant hepatitis B
  15. The Management of Gastroprotection in Patients Receiving Antiplatelet Agents – Focus on Clopidogrel and PPI
  16. High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy
  17. 211 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF 2-YEARS CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
  18. 691 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDY
  19. P.11.17 INDOCYANINE GREEN CLEARANCE (ICG) AS A PREDICTOR OF CLINICAL DECOMPENSATION AND MORTALITY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS
  20. P.18.22 SERUM FGF19 LEVELS ARE INDEPENDENTLY RELATED TO BMI IN HEALTHY BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING STUDY
  21. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience
  22. Chronic NSAIDs Therapy and Upper Gastrointestinal Tract – Mechanism of Injury, Mucosal Defense, Risk Factors for Complication Development and Clinical Management
  23. Severe acute autoimmune hepatitis after natalizumab treatment
  24. 1275 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
  25. P.19.13 AUTOIMMUNE GASTRITIS ASSOCIATES WITH DUODENAL LYMPHOCYTOSIS
  26. P.15.17 TELBIVUDINE TREATMENT FOR FULMINANT HBV HEPATITIS
  27. P.14.8 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY FOR DIFFICULT BILE DUCT STONES: COMPARISON BETWEEN TWO DIFFERENT LITHOTRIPTERS
  28. P.04.3 SERUM CHENODEOXYCHOLIC ACID, BMI AND TG, ARE INDEPENDENTLY RELATED TO INSULIN-RESISTANCE IN BLOOD DONORS: AN INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE STUDY
  29. Erratum to: High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On
  30. Alisporivir for the treatment of chronic HCV
  31. High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-On
  32. P.1.17: INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASE
  33. P.1.79: INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
  34. 953 INDOCYANINE GREEN CLEARANCE AS A MARKER OF DECOMPENSATION AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS
  35. 171 INDOCYANINE GREEN AS A PREDICTOR OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN A PROSPECTIVE COHORT STUDY OF PATIENTS WITH CHRONIC LIVER DISEASE
  36. The Pharmacological Management of Intrahepatic Cholestasis of Pregnancy
  37. F-13 Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
  38. Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations
  39. P.237 UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
  40. T.N.4 UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
  41. 258 HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
  42. 654 A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
  43. A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
  44. HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
  45. SERUM BILE ACIDS IN PHYSIOLOGICAL PREGNANCY: COMPARISON WITH NON PREGNANT WOMEN
  46. Chronic hepatitis B in 2008
  47. PA.190 DAILY LONG TERM ALFA-IFN IN HCV RECURRENCE AFTER LIVER TRANSPLANTATION: RESULTS OF AN ONGOING STUDY
  48. PO.27 TREATMENT OF ACUTE HEPATITIS B WITH HIGH DOSE LAMIVUDINE
  49. Lamivudine treatment for severe acute HBV hepatitis